REGN — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
Regeneron Pharmaceuticals, Inc.
Healthcare · $612.14
3.3
/10
Weak Entry
↓ -1.0 today
Put-selling entry timing — not a quality rating.A strong long-term holding can still show a low score today (thin premium, extended trend, or turning momentum).
How this score works → Try the calculator ↓
Regime
Bearish
vs SMA200
SMA200 Distance
-12.1%
Below trend
Volatility
Normal
Average premiums
Momentum
Accelerating
2nd day
About Regeneron Pharmaceuticals, Inc.
Regeneron earns most revenue from Dupixent (immunology blockbuster, $14B+ global sales) and Eylea (ophthalmology). Low beta (~0.4) despite biotech classification — driven by high-margin recurring drug sales. Pays a token ~0.5% dividend; moderate IV with periodic spikes around FDA decisions and earnings.
Biotechnology
Market Cap
$64.2B
P/E Ratio
14.9
Dividend
0.61%
Beta
0.24
52-Week Range Current: $612.14
$503.25 $821.11
Earnings
2026-07-30
47 days away

REGN — lower-band read with the weakness spread across dimensions rather than concentrated in one. The composite picture, not any single indicator, is the limiting factor.

Based on end-of-day market dataScored by ThetaLoop Research
REGN ranks #12 of 66 Healthcare tickers by put-selling score (622 total screened)

Position Size & Yield Calculator

Live model for REGN — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
APT Alpha Pro Tech, Ltd. 7.9 SMMT Summit Therapeutics Inc. 6.9 BMY Bristol-Myers Squibb Company 6.8 NVAX Novavax, Inc. 5.6 SRPT Sarepta Therapeutics, Inc. 4.9 Browse all Healthcare tickers →
📌 Embed this score on your blog
The REGN X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/REGN" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/REGN">REGN X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Full Research Track Record — All Wins AND Losses
Cash-Secured Puts ↗ · See a sample →